141 related articles for article (PubMed ID: 24503408)
1. In vivo intraocular distribution and safety of periocular nanoparticle carboplatin for treatment of advanced retinoblastoma in humans.
Kalita D; Shome D; Jain VG; Chadha K; Bellare JR
Am J Ophthalmol; 2014 May; 157(5):1109-15. PubMed ID: 24503408
[TBL] [Abstract][Full Text] [Related]
2. Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma.
Schmack I; Hubbard GB; Kang SJ; Aaberg TM; Grossniklaus HE
Am J Ophthalmol; 2006 Aug; 142(2):310-5. PubMed ID: 16876514
[TBL] [Abstract][Full Text] [Related]
3. Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds.
Smith SJ; Pulido JS; Salomão DR; Smith BD; Mohney B
Br J Ophthalmol; 2012 Aug; 96(8):1073-7. PubMed ID: 22368261
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of systemic versus focal Carboplatin chemotherapy in the rabbit eye: possible implication in the treatment of retinoblastoma.
Hayden BC; Jockovich ME; Murray TG; Voigt M; Milne P; Kralinger M; Feuer WJ; Hernandez E; Parel JM
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3644-9. PubMed ID: 15452072
[TBL] [Abstract][Full Text] [Related]
5. Carboplatin loaded polymethylmethacrylate nano-particles in an adjunctive role in retinoblastoma: an animal trial.
Shome D; Kalita D; Jain V; Sarin R; Maru GB; Bellare JR
Indian J Ophthalmol; 2014 May; 62(5):585-9. PubMed ID: 24881606
[TBL] [Abstract][Full Text] [Related]
6. Intraocular carboplatin concentrations following intravenous administration for human intraocular retinoblastoma.
Abramson DH; Frank CM; Chantada GL; de Totah AB; de Pifano IT; Ramírez GT; Gomez RT; Fandino AT; Tran HT; Madden TJ; Dunkel IJ
Ophthalmic Genet; 1999 Mar; 20(1):31-6. PubMed ID: 10415463
[TBL] [Abstract][Full Text] [Related]
7. Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma.
Mulvihill A; Budning A; Jay V; Vandenhoven C; Heon E; Gallie BL; Chan HS
Arch Ophthalmol; 2003 Aug; 121(8):1120-4. PubMed ID: 12912689
[TBL] [Abstract][Full Text] [Related]
8. Management and outcome of retinoblastoma with vitreous seeds.
Manjandavida FP; Honavar SG; Reddy VA; Khanna R
Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal carboplatin concentration and area under concentration versus time curve after intravitreal and periocular delivery.
Pochop P; Darsova D; Kukacka J; Tesfaye H; Vajner L; Uhlik J; Kodetová D; Malis J; Dotrelova D
Eur J Ophthalmol; 2010; 20(4):745-51. PubMed ID: 20306443
[TBL] [Abstract][Full Text] [Related]
10. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
11. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
[TBL] [Abstract][Full Text] [Related]
12. Orbital fibrosis and intraocular recurrence of retinoblastoma following periocular carboplatin.
Kim JW; Yau JW; Moshfeghi D; Fishman M
J Pediatr Ophthalmol Strabismus; 2010 May; 47 Online():e1-4. PubMed ID: 21214147
[TBL] [Abstract][Full Text] [Related]
13. Severe pseudo-preseptal cellulitis following sub-Tenon's carboplatin injection for intraocular retinoblastoma.
Kiratli H; Kocabeyoğlu S; Bilgiç S
J AAPOS; 2007 Aug; 11(4):404-5. PubMed ID: 17306997
[TBL] [Abstract][Full Text] [Related]
14. Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track.
Munier FL; Soliman S; Moulin AP; Gaillard MC; Balmer A; Beck-Popovic M
Br J Ophthalmol; 2012 Aug; 96(8):1084-7. PubMed ID: 22368262
[TBL] [Abstract][Full Text] [Related]
15. Periocular carboplatin for retinoblastoma: long-term report (12 years) on efficacy and toxicity.
Marr BP; Dunkel IJ; Linker A; Abramson DH
Br J Ophthalmol; 2012 Jun; 96(6):881-3. PubMed ID: 22328819
[TBL] [Abstract][Full Text] [Related]
16. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
Schaiquevich P; Ceciliano A; Millan N; Taich P; Villasante F; Fandino AC; Dominguez J; Chantada GL
Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125
[TBL] [Abstract][Full Text] [Related]
17. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma.
Van Quill KR; Dioguardi PK; Tong CT; Gilbert JA; Aaberg TM; Grossniklaus HE; Edelhauser HF; O'Brien JM
Ophthalmology; 2005 Jun; 112(6):1151-8. PubMed ID: 15885791
[TBL] [Abstract][Full Text] [Related]
18. Severe aseptic orbital cellulitis with subtenon carboplatin for intraocular retinoblastoma.
Shah PK; Kalpana N; Narendran V; Ramakrishnan M
Indian J Ophthalmol; 2011; 59(1):49-51. PubMed ID: 21157073
[TBL] [Abstract][Full Text] [Related]
19. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma.
Abramson DH; Frank CM; Dunkel IJ
Ophthalmology; 1999 Oct; 106(10):1947-50. PubMed ID: 10519590
[TBL] [Abstract][Full Text] [Related]
20. A phase I study of periocular topotecan in children with intraocular retinoblastoma.
Chantada GL; Fandino AC; Carcaboso AM; Lagomarsino E; de Davila MT; Guitter MR; Rose AB; Manzitti J; Bramuglia GF; Abramson DH
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1492-6. PubMed ID: 18978345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
